Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.

Wai, Bryan

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control. [electronic resource] - Cardiovascular diabetology Feb 2012 - 14 p. digital

Publication Type: Journal Article

1475-2840

10.1186/1475-2840-11-14 doi


Adrenergic beta-Antagonists--therapeutic use
Aged
Aged, 80 and over
Albuminuria--etiology
Biomarkers--blood
Bisoprolol--therapeutic use
Carbazoles--therapeutic use
Carvedilol
Diabetes Mellitus, Type 2--blood
Diabetic Nephropathies--etiology
Female
Glomerular Filtration Rate--drug effects
Glycated Hemoglobin--metabolism
Heart Failure, Systolic--complications
Hospitals, Teaching
Humans
Hypoglycemic Agents--therapeutic use
Lipids--blood
Male
Middle Aged
Propanolamines--therapeutic use
Prospective Studies
Time Factors
Treatment Outcome
Victoria